We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
Read MoreHide Full Article
CME Group (CME - Free Report) is slated to report fourth-quarter 2022 earnings on Feb 8, before market open. CME delivered an earnings surprise in each of the last four quarters, the average being 2.98%.
Factors to Consider
An increase in clearing, transaction fees and other revenues, and market data and information services is likely to have aided revenues in the to-be-reported quarter. The Zacks Consensus Estimate for the top line is pegged at $1.2 billion, indicating an increase of 5.5% from the year-ago reported figure.
Increased volatility driving higher volumes is likely to have benefited clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees is pegged at $995 million, indicating an increase of 4.8% from the year-ago reported figure.
Recently, CME Group reported solid average daily volume (ADV) for 2022. ADV of record 23.3 million contracts increased 19% year over year, driven by growth in Equity Index of 39% and Foreign Exchange products of 24%.
Market data and information services revenues are likely to have increased owing to price increases for certain device fees. The consensus estimate for market data and information services is pegged at $154 million, indicating an increase of 8.5% from the year-ago reported figure.
Expenses are likely to have decreased in the to-be-reported quarter due to lower compensation and benefits, technology, reduced professional fees and outside services, amortization of purchased intangibles, lower depreciation and amortization.
The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.90, indicating an increase of 14.5% from the year-ago quarter reported figure.
What the Zacks Model Says
Our proven model predicts an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for an earnings beat.
Earnings ESP: CME Group has an Earnings ESP of +0.05%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Some stocks worth considering from the finance sector with a perfect mix of elements to surpass estimates in their upcoming quarterly releases are as follows:
AssetMark Financial (AMK - Free Report) has an Earnings ESP of +2.30% and a Zacks Rank of 2. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at 44 cents per share, indicating an increase of 33.3% from the year-ago reported figure.
AMK’s earnings beat estimates in three of the last four reported quarters, while missing in the other one.
Ares Capital (ARCC - Free Report) has an Earnings ESP of +8.28% and a Zacks Rank #2. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at 56 cents, implying a decline of 7.7% from the figure reported in the year-ago quarter.
ARCC’s earnings beat estimates in two of the last four reported quarters, missed in one and met estimates in one.
Credicorp (BAP - Free Report) has an Earnings ESP of +8.33% and a Zacks Rank of 1. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at $3.92, indicating an increase of 18.8% from the year-ago reported figure.
BAP’s earnings beat estimates in two of the last four reported quarters, while missing in the other two.
Image: Bigstock
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
CME Group (CME - Free Report) is slated to report fourth-quarter 2022 earnings on Feb 8, before market open. CME delivered an earnings surprise in each of the last four quarters, the average being 2.98%.
Factors to Consider
An increase in clearing, transaction fees and other revenues, and market data and information services is likely to have aided revenues in the to-be-reported quarter. The Zacks Consensus Estimate for the top line is pegged at $1.2 billion, indicating an increase of 5.5% from the year-ago reported figure.
Increased volatility driving higher volumes is likely to have benefited clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees is pegged at $995 million, indicating an increase of 4.8% from the year-ago reported figure.
Recently, CME Group reported solid average daily volume (ADV) for 2022. ADV of record 23.3 million contracts increased 19% year over year, driven by growth in Equity Index of 39% and Foreign Exchange products of 24%.
Market data and information services revenues are likely to have increased owing to price increases for certain device fees. The consensus estimate for market data and information services is pegged at $154 million, indicating an increase of 8.5% from the year-ago reported figure.
Expenses are likely to have decreased in the to-be-reported quarter due to lower compensation and benefits, technology, reduced professional fees and outside services, amortization of purchased intangibles, lower depreciation and amortization.
The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.90, indicating an increase of 14.5% from the year-ago quarter reported figure.
What the Zacks Model Says
Our proven model predicts an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for an earnings beat.
Earnings ESP: CME Group has an Earnings ESP of +0.05%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: CME Group currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Some stocks worth considering from the finance sector with a perfect mix of elements to surpass estimates in their upcoming quarterly releases are as follows:
AssetMark Financial (AMK - Free Report) has an Earnings ESP of +2.30% and a Zacks Rank of 2. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at 44 cents per share, indicating an increase of 33.3% from the year-ago reported figure.
AMK’s earnings beat estimates in three of the last four reported quarters, while missing in the other one.
Ares Capital (ARCC - Free Report) has an Earnings ESP of +8.28% and a Zacks Rank #2. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at 56 cents, implying a decline of 7.7% from the figure reported in the year-ago quarter.
ARCC’s earnings beat estimates in two of the last four reported quarters, missed in one and met estimates in one.
Credicorp (BAP - Free Report) has an Earnings ESP of +8.33% and a Zacks Rank of 1. The Zacks Consensus Estimate for fourth-quarter 2022 earnings is pegged at $3.92, indicating an increase of 18.8% from the year-ago reported figure.
BAP’s earnings beat estimates in two of the last four reported quarters, while missing in the other two.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.